Comparative Safety of New Oral Anticoagulants in Nonvalvular Atrial Fibrillation Patients － A Multiple-Center Study

Comparative Safety of New Oral Anticoagulants in Nonvalvular Atrial Fibrillation Patients － A Multiple-Center Study

碩士 === 國立成功大學 === 臨床藥學與藥物科技研究所 === 104

Bibliographic Details
Main Authors:	Chin-LinHsieh, 謝沁凌
Other Authors:	Ching-Lan Cheng
Format:	Others
Language:	zh-TW
Published:	2016
Online Access:	http://ndltd.ncl.edu.tw/handle/b67t5u

Similar Items

Assessment on Safety of New Oral Anticoagulants for Nonvalvular Atrial Fibrillation – A Single Medical Center Experience
by: Ying-HsuanLai, et al.
Published: (2014)

Outpatient Management of Oral Anticoagulation Therapy in Patients with Nonvalvular Atrial Fibrillation
by: Aida Kulo, et al.
Published: (2009-11-01)

Current guidelines and prospects for using novel oral anticoagulants for nonvalvular atrial fibrillation
by: A. V. Fonyakin
Published: (2014-12-01)

NOVEL ANTICOAGULANTS FOR THROMBOEMBOLIC COMPLICATIONS PREVENTION IN NONVALVULAR ATRIAL FIBRILLATION
by: D. A. Itkin, et al.
Published: (2015-02-01)

Cost-Effectiveness of Anticoagulation in Patients with Nonvalvular Atrial Fibrillation with Edoxaban Compared to Warfarin in Germany
by: Martin Krejczy, et al.
Published: (2015-01-01)

Anticoagulants in Older Patients with Nonvalvular Atrial Fibrillation after Intracranial Hemorrhage
by: Sylvie Perreault, et al.
Published: (2019-05-01)

Direct oral anticoagulants: key considerations for use to prevent stroke in patients with nonvalvular atrial fibrillation
by: Ment J
Published: (2015-06-01)

Usage of oral anticoagulant and influencing factors in nonvalvular atrial fibrillation: an analysis of 3 984 inpatients
by: XIANG Jing, et al.
Published: (2021-06-01)

New oral anticoagulants in patients with nonvalvular atrial fibrillation: a review of pharmacokinetics, safety, efficacy, quality of life, and cost effectiveness
by: Mani H, et al.
Published: (2014-06-01)

Switching to Another Oral Anticoagulant and Drug Discontinuation Among Elderly Patients With Nonvalvular Atrial Fibrillation Treated With Different Direct Oral Anticoagulants
by: Christine L. Baker JD, MPH, et al.
Published: (2019-08-01)

Efficacy and Safety of Non-Vitamin K Antagonist Oral Anticoagulants in Asians With Nonvalvular Atrial Fibrillation: A Network Meta-Analysis
by: Qinmei Xiong MD, PhD, et al.
Published: (2019-11-01)

Nine‐year trend of oral anticoagulant use in patients with embolic stroke due to nonvalvular atrial fibrillation
by: Chisa Asahina, et al.
Published: (2020-10-01)

Setting priorities in the health care sector – the case of oral anticoagulants in nonvalvular atrial fibrillation in Denmark
by: Poulsen PB, et al.
Published: (2017-10-01)

Factors associated with primary nonadherence to newly initiated direct oral anticoagulants in patients with nonvalvular atrial fibrillation
by: Ballarin, E., et al.
Published: (2021)

The use status of anticoagulation drugs for inpatients with nonvalvular atrial fibrillation in Southwest China
by: Zheng HJ, et al.
Published: (2017-03-01)

PRACTICAL CONCERNS OF ANTICOAGULATION IN NONVALVULAR ATRIAL FIBRILLATION: A UNIVERSITY CLINICS REGISTRY
by: A. A. Sokolova, et al.
Published: (2015-09-01)

Anticoagulation control among patients with nonvalvular atrial fibrillation: A single tertiary cardiac center experience
by: Shaban Mohammed, et al.
Published: (2017-01-01)

Quality of anticoagulation among patients with nonvalvular atrial fibrillation in the Primary health care center 'Novi Beograd'
by: Lončar Ana M.
Published: (2017-01-01)

Biomarkers for Predicting Left Atrial or Left Atrial Appendage Thrombus in Anticoagulated Patients with Nonvalvular Atrial Fibrillation
by: Xue Zhou, et al.
Published: (2020-01-01)

The differences of atrial thrombus locations and variable response to anticoagulation in nonvalvular atrial fibrillation with ventricular cardiomyopathy
by: Hao Zhang, et al.
Published: (2020-12-01)

Main factors of adherence to new oral anticoagulants and its dynamics in outpatients with nonvalvular atrial fibrillation: results of the ANTEY study
by: Yu. V. Lukina, et al.
Published: (2020-11-01)

Utilization of Anticoagulants in Nonvalvular Atrial Fibrillation Before and After Catheter Ablation at Shanghai, China
by: Chen Tingting BS, et al.
Published: (2019-02-01)

Features of Modern Anticoagulant Therapy in Patients with Nonvalvular Atrial Fibrillation and Chronic Kidney Disease
by: I. S. Daabul, et al.
Published: (2016-11-01)

National Physician Survey for Nonvalvular Atrial Fibrillation (NVAF) Anticoagulation Comparing Knowledge, Attitudes and Practice of Cardiologist to PCPs
by: Haseeb Saeed MD, et al.
Published: (2020-10-01)

The Use of Direct Oral Anticoagulants for Prevention of Stroke and Systemic Embolic Events in East Asian Patients with Nonvalvular Atrial Fibrillation
by: Chang-Sheng Ma, MD
Published: (2018-07-01)

Health-related quality of life in nonvalvular atrial fibrillation patients with controlled or uncontrolled anticoagulation status
by: José Felipe Varona, et al.
Published: (2020-12-01)

New oral anticoagulants for atrial fibrillation
by: Yuliana Yakobus
Published: (2017-06-01)

New oral anticoagulants in atrial fibrillation
by: L. Sumithra, et al.
Published: (2014-11-01)

Elderly Bleeding Risk of Direct Oral Anticoagulants in Nonvalvular Atrial Fibrillation: A Systematic Review and Meta-Analysis of Cohort Studies
by: Jessika Lobraico-Fernandez, et al.
Published: (2019-05-01)

A Renal Function Based Trade-Off Analysis of Non-vitamin K Antagonist Oral Anticoagulants in Nonvalvular Atrial Fibrillation
by: Ling-Yun Zhou, et al.
Published: (2018-11-01)

Practice Variations in the Use of Novel Oral Anticoagulants for Nonvalvular Atrial Fibrillation-Related Stroke among Stroke Neurologists in Saudi Arabia
by: Mohammed H. Alanazy, et al.
Published: (2019-01-01)

Reducing age bias in decision analyses of anticoagulation for patients with nonvalvular atrial fibrillation - A microsimulation study.
by: Matthew A Pappas, et al.
Published: (2018-01-01)

Correction to: Health-related quality of life in nonvalvular atrial fibrillation patients with controlled or uncontrolled anticoagulation status
by: José Felipe Varona, et al.
Published: (2021-04-01)

Safety of once- or twice-daily dosing of non-vitamin K antagonist oral anticoagulants (NOACs) in patients with nonvalvular atrial fibrillation: A NOAC-TR study
by: Sadık Volkan Emren, et al.
Published: (2018-05-01)

Oral anticoagulants for stroke prevention in nonvalvular AF
by: Medlinskiene, Kristina, et al.
Published: (2018)

Differences in outcomes between oral anticoagulation “new starters” and “switchers” in patients with nonvalvular atrial fibrillation: A pooled analysis of the AMADEUS and BOREALIS trials
by: Ying Bai, et al.
Published: (2019-12-01)

Traditional warfarin (Coumadin) therapy usage experience on nonvalvular atrial fibrillation before non-Vitamin K antagonists (new oral anticoagulants) era from a center in Turkey
by: Emre Ozdemir, et al.
Published: (2020-01-01)

ANTITHROMBOTIC THERAPY IN NONVALVULAR ATRIAL FIBRILLATION: PROBLEMS AND PROSPECTS
by: A. Y. Rychkov, et al.
Published: (2016-01-01)

Prevalence of oral anticoagulation in atrial fibrillation
by: Eduardo Bartholomay, et al.
Published: (2014-09-01)

THE EFFICACY AND SAFETY OF NEW ORAL ANTICOAGULANTS IN PATIENTS WITH ATRIAL FIBRILLATION IN CLINICAL PRACTICE
by: S. V. Moiseev
Published: (2016-05-01)